Treatment with Cana at 10 mg/kg and 20 mg/kg reduced SIRT1 levels to 60.9% and 41.1% of the HCC group, respectively (p ≤ 0.05). This evidence concerns the gene SIRT1 and hepatocellular carcinoma.